ACTA NEUROLOGICA SCANDINAVICA

Scope & Guideline

Innovating Understanding of Neurological Disorders

Introduction

Welcome to the ACTA NEUROLOGICA SCANDINAVICA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of ACTA NEUROLOGICA SCANDINAVICA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0001-6314
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1961 to 2024
AbbreviationACTA NEUROL SCAND / Acta Neurol. Scand.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

ACTA NEUROLOGICA SCANDINAVICA focuses on advancing the field of neurology through the publication of original research articles, reviews, and case reports that address various neurological disorders. The journal aims to provide a platform for innovative studies that enhance our understanding of neurological conditions and improve clinical practices.
  1. Neurological Disorders Research:
    The journal covers a wide range of neurological disorders, including but not limited to epilepsy, multiple sclerosis, stroke, and neurodegenerative diseases. This focus allows for a comprehensive understanding of the complexities and treatment challenges associated with these conditions.
  2. Clinical and Translational Studies:
    ACTA NEUROLOGICA SCANDINAVICA emphasizes clinical studies that bridge laboratory research and patient care. This includes trials on new therapeutic interventions, observational studies, and cohort studies that provide insights into treatment outcomes and disease progression.
  3. Neuroimaging and Biomarkers:
    The journal publishes research related to neuroimaging techniques and biomarker studies that aim to improve diagnostic accuracy and prognostic assessments in various neurological disorders.
  4. Quality of Life and Patient-Centered Research:
    A significant focus on understanding the quality of life and psychosocial aspects of living with neurological conditions, reflecting a patient-centered approach to neurological healthcare.
  5. Epidemiological Studies:
    The journal includes epidemiological research that explores the prevalence, incidence, and risk factors associated with neurological diseases, contributing to public health knowledge and policy.
Recent publications in ACTA NEUROLOGICA SCANDINAVICA reflect evolving interests and trends within the field of neurology. This section highlights emerging themes that have gained traction in the journal's recent issues.
  1. COVID-19 and Neurological Implications:
    There is an increasing focus on the neurological implications of COVID-19, including studies on post-viral syndromes, neurological sequelae, and the impact of the pandemic on patients with pre-existing neurological conditions.
  2. Telemedicine and Digital Health:
    Research exploring the role of telemedicine and digital health interventions in managing neurological conditions is on the rise. This includes studies on remote monitoring, tele-rehabilitation, and the use of digital tools to enhance patient care.
  3. Quality of Life and Mental Health in Neurology:
    An emerging trend is the focus on quality of life and mental health outcomes for patients with neurological disorders. Research is increasingly addressing the psychosocial aspects of these conditions, including fatigue, depression, and cognitive impairment.
  4. Neuroimaging Advances:
    There is a growing interest in advanced neuroimaging techniques and their applications in understanding neurological diseases. Studies utilizing machine learning and artificial intelligence for neuroimaging analysis are becoming more prevalent.
  5. Personalized Medicine Approaches:
    The journal is seeing an increase in studies that explore personalized medicine approaches in neurology, including genetic profiling and tailored treatment strategies for neurological disorders.

Declining or Waning

While ACTA NEUROLOGICA SCANDINAVICA has maintained a strong focus on several key areas, there are certain themes and methodologies that appear to be declining in prominence over recent years. This section identifies those waning scopes.
  1. Basic Science and Animal Studies:
    There has been a noticeable decrease in the publication of basic science research and animal studies. The journal is increasingly prioritizing clinical applications and patient-centered research, reflecting a shift towards studies that directly impact patient care.
  2. Historical and Review Articles:
    Although still relevant, the number of historical perspectives and extensive review articles has diminished. The journal seems to favor original research that presents new findings and methodologies over comprehensive literature reviews.
  3. Pharmacological Studies:
    Research focused solely on pharmacological treatments, particularly those that do not incorporate clinical outcomes or patient experiences, has seen a decline. The trend is moving towards studies that integrate pharmacology with real-world clinical data.

Similar Journals

Annals of Indian Academy of Neurology

Pioneering Clinical Advancements in Neurology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

PRACTICAL NEUROLOGY

Advancing Neurological Insights for Better Patient Care
Publisher: BMJ PUBLISHING GROUPISSN: 1474-7758Frequency: 6 issues/year

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

NEUROLOGIA

Shaping the Future of Neurology Through Rigorous Research
Publisher: ELSEVIER ESPANA SLUISSN: 0213-4853Frequency: 9 issues/year

NEUROLOGIA, an esteemed journal published by ELSEVIER ESPANA SLU, stands at the forefront of the field of neurology, with a dedicated focus on innovative research and clinical practice since its inception in 1973. As an Open Access journal since 2017, it champions the dissemination of knowledge, allowing researchers, professionals, and students alike to access cutting-edge findings in neurology without barriers. With an impressive Scopus rank of #115 in the clinical neurology category, placing it in the 71st percentile, NEUROLOGIA is categorized as Q3 in both general medicine and clinical neurology, reflecting its impact and relevance in a rapidly evolving field. Based in Barcelona, Spain, the journal's commitment to advancing understanding of neurological conditions is underscored by its rigorous peer-review process and engagement with a global audience. As it continues to publish vital research that shapes clinical practices and informs policy, NEUROLOGIA remains an integral resource for those striving to improve outcomes in neurology.

Archives of Neuroscience

Empowering the neuroscience community with open access knowledge.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Neurology and Clinical Neuroscience

Empowering professionals with cutting-edge neurological research.
Publisher: WILEYISSN: 2049-4173Frequency: 6 issues/year

Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.

NEUROMUSCULAR DISORDERS

Advancing knowledge in neuromuscular health.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

NEUROLOGICAL SCIENCES

Pioneering insights in clinical neurology and mental health.
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 1590-1874Frequency: 12 issues/year

NEUROLOGICAL SCIENCES, published by SPRINGER-VERLAG ITALIA SRL, is a premier journal that has been a cornerstone in the field of neurology and related disciplines since its inception in 1996. With an impressive Q1 ranking in Dermatology and Q2 rankings in Neuroloy (clinical) as well as Psychiatry and Mental Health, this journal consistently delivers high-quality peer-reviewed research that informs and shapes clinical practice. The journal boasts a significant presence on Scopus, positioned in the 89th percentile for Dermatology, 73rd for Psychiatry and Mental Health, and 72nd for Neurology (clinical), reflecting its influential contributions to medical knowledge. Open Access options are available, ensuring that this valuable research is accessible to a wider audience committed to advancing their understanding of neurological sciences. As it converges into future years (2024 and beyond), NEUROLOGICAL SCIENCES aims to continue foster collaboration and innovation amongst researchers, professionals, and students within the neurology and mental health domains, making it an indispensable resource for those dedicated to improving patient outcomes and advancing scholarly dialogue.

NEUROLOGICAL RESEARCH

Exploring Breakthroughs in Neurological Research
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

NEUROLOGIC CLINICS

Connecting research and clinical excellence in neurology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

EUROPEAN NEUROLOGY

Exploring Neurological Innovations Since 1897
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.